FDA Device Intelligence
HomeABBOTT LABORATORIES › Alinity-Architect

Alinity-Architect

ABBOTT LABORATORIES · Model 01P0603 · UDI-DI 00380740168209

MLMMKWNRP Prescription
9
510(k) clearances
327
Adverse events
12
Recalls
13
Facilities

Description

Transplant Pretreatment Tubes

Recalls

DateFirmReason
2026-05-07Siemens Healthcare Diagnostics, Inc.A potential positive bias in quality control (QC) and patient sample results in three lots of the Dimension Tacrolimus (TAC) Flex reagent cartridge.
2023-01-30Siemens Healthcare Diagnostics, Inc.Siemens Healthineers has received customer complaints and confirmed imprecision for Quality Control (QC) and patient samples with Dimension Tacrolimus (TAC) lots GA2286, GA3047 and
2022-01-20Microgenics CorporationDue to QMS Tacrolimus Calibrator recovering between 82 to 94% of their target values, resulting in over-quantitation in tacrolimus patient result values when used with the QMS Tacr
2017-06-29Siemens Healthcare Diagnostics, Inc.Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely ele
2015-03-16Diasorin Inc.Instability in the PRO-Trac II Tacrolimus ELISA kit which may cause falsely elevated patient results.
2013-07-01Siemens Healthcare Diagnostics, Inc.Siemens initiated a recall due to confirmed complaints of low patient sample recovery with Dimension TACR Flex Reagent cartridge (DF107) lot BB4087 and its linked calibrator (DC 10
2013-04-25Siemens Healthcare Diagnostics, Inc.Siemens has confirmed that the TACR method may demonstrate reduced on-board stability which may result in imprecise and inaccurate QC and patient results.
2012-11-27Siemens Healthcare Diagnostics, Inc.Siemens has confirmed customer complaints of low patient sample recovery with Dimension(R) TACR Flex(R) lot FA3085. Quality Control (QC) materials have not exhibited low recover
2010-09-07Abbott LaboratoriesThere are reagent barcode read errors when using reagent lot 86599M500 due to the print quality of the barcode.
2010-06-15Siemens Healthcare Diagnostics, Inc.Low patient sample recovery results in all affected lots, with possibility of inappropriate increase in tacrolimus dosage based on false low result.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.